 It's less expensive, it's more available, and it works better. So this is a vaccine that was designed and developed in 2012 and has been progressing since then. And previous vaccines haven't been able to build on what was known previously and develop something that really is at a price point where it's realistic to roll this out in many tens of millions of doses from now on.